NGVT RSI Chart
Last 7 days
4.7%
Last 30 days
-0.5%
Last 90 days
-0.9%
Trailing 12 Months
-36.6%
Historical Charts for Stock Metrics
Year | Q1 | Q2 | Q3 | Q4 |
---|---|---|---|---|
2023 | 1.7B | 1.7B | 1.7B | 1.7B |
2022 | 1.5B | 1.5B | 1.6B | 1.7B |
2021 | 1.2B | 1.3B | 1.4B | 1.4B |
2020 | 1.3B | 1.2B | 1.2B | 1.2B |
2019 | 1.2B | 1.2B | 1.3B | 1.3B |
2018 | 989.1M | 1.0B | 1.1B | 1.1B |
2017 | 927.2M | 942.1M | 953.8M | 972.4M |
2016 | 923.4M | 908.9M | 906.5M | 908.3M |
2015 | 1.0B | 996.9M | 977.6M | 958.3M |
2014 | 0 | 0 | 0 | 1.0B |
Datesorted ascending | Name | Buy/Sell | $ Value | Avg. Price | # Shares | Title |
---|---|---|---|---|---|---|
Feb 28, 2024 | white richard allen jr | acquired | - | - | 8,236 | svp and pres, perf chemicals |
Feb 28, 2024 | woodcock stuart edward jr. | sold (taxes) | -37,030 | 45.27 | -818 | evp and pres, perf materials |
Feb 28, 2024 | stunyo christine | sold (taxes) | -15,889 | 45.27 | -351 | svp, chief hr officer |
Feb 28, 2024 | hall mary dean | acquired | - | - | 12,710 | evp & cfo |
Feb 28, 2024 | woodcock stuart edward jr. | acquired | - | - | 9,201 | evp and pres, perf materials |
Feb 28, 2024 | platt phillip john | acquired | - | - | 3,591 | cao & vp, bus transform lead |
Feb 28, 2024 | hulme steven paul | sold (taxes) | -11,181 | 45.27 | -247 | svp and pres, apt |
Feb 28, 2024 | fortson john c. | sold (taxes) | -207,880 | 45.27 | -4,592 | president & ceo |
Feb 28, 2024 | cozad stacy | sold (taxes) | -28,384 | 45.27 | -627 | evp, gen. counsel & secretary |
Feb 28, 2024 | white richard allen jr | sold (taxes) | -24,128 | 45.27 | -533 | svp and pres, perf chemicals |
Which funds bought or sold NGVT recently?
View All DetailsDatesorted ascending | Fund Name | Type | % Chg | $ Change | $ Held | % Portfolio |
---|---|---|---|---|---|---|
Mar 22, 2024 | PNC FINANCIAL SERVICES GROUP, INC. | reduced | -12.22 | -90,084 | 606,070 | -% |
Mar 22, 2024 | Livelsberger Financial Advisory | new | - | 2,030 | 2,030 | -% |
Mar 21, 2024 | HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND | unchanged | - | -781 | 94,487 | -% |
Mar 11, 2024 | VANGUARD GROUP INC | added | 4.28 | 5,849,670 | 176,760,000 | -% |
Mar 01, 2024 | GOLDMAN SACHS GROUP INC | added | 79.92 | 4,714,370 | 10,723,900 | -% |
Mar 01, 2024 | Pineridge Advisors LLC | new | - | 1,889 | 1,889 | -% |
Feb 28, 2024 | AMERICAN INTERNATIONAL GROUP, INC. | reduced | -0.8 | -15,326 | 933,256 | -% |
Feb 26, 2024 | TEACHERS RETIREMENT SYSTEM OF THE STATE OF KENTUCKY | unchanged | - | -4,000 | 523,000 | -% |
Feb 20, 2024 | Quarry LP | reduced | -68.5 | -19,641 | 8,925 | -% |
Feb 16, 2024 | HARBOUR INVESTMENTS, INC. | unchanged | - | -6.00 | 803 | -% |
Unveiling Ingevity Corp's Major ShareHolders
Date Filed | Name of Filer | Percent of Class | No. of Shares | Form Type | |
---|---|---|---|---|---|
Stocks Marked 'Very Cheap' by Grufity's Fair Value Model Have Outperformed Russell 2000 Index
Small Caps and Mid Caps are mostly overlooked by investors as all the focus goes to Magnificent 7. These stocks that are not part of the beauty contest require a deeper look. However, all large cap stocks were once small caps. Grufity's Fair Value model opens up this unverse as it separates high-performing, rewarding stocks from low-performing risky stocks. <b>Russell 2000 stocks that were marked 'Very Cheap' by the model doubled in three years while the index was flat.</b>
Returns of $10,000 invested in:
Very Cheap Stocks: $21,859
Russell 2000 Index: $10,334
Very Expensive Stocks: $8,224
Russell 2000 stocks considered 'Very Cheap' by the model greatly outperformed Russell 2000 index and the 'Very Expensive' bucket over past three years.
Peers (Alternatives to Ingevity Corp)
Name | Mkt Capsorted ascending | Revenue | Price %, 1M | Returns, 1Y | P/E | P/S | Rev 1-Yr | Inc 1-Yr |
---|---|---|---|---|---|---|---|---|
LARGE-CAP | ||||||||
APD | 54.1B | 12.4B | 23.14 | 4.35 | ||||
DOW | 41.0B | 44.6B | 62.17 | 0.92 | ||||
CE | 18.5B | 10.9B | 9.43 | 1.69 | ||||
AVTR | 17.3B | 7.0B | 54.01 | 2.49 | ||||
ALB | 15.1B | 9.6B | 9.61 | 1.57 | ||||
EMN | 11.7B | 9.2B | 13.07 | 1.27 | ||||
MID-CAP | ||||||||
CBT | 5.1B | 3.9B | 11.45 | 1.3 | ||||
BCPC | 5.0B | 922.4M | 45.92 | 5.4 | ||||
AVNT | 3.9B | 3.1B | 51.51 | 1.25 | ||||
ARCH | 3.0B | 3.1B | 6.45 | 0.95 | ||||
SMALL-CAP | ||||||||
CCF | 1.2B | 404.0M | 36.59 | 3 | ||||
ASIX | 735.6M | 1.5B | 13.47 | 0.48 | ||||
CMT | 167.5M | 357.7M | 8.24 | 0.47 | ||||
AREC | 113.5M | 21.4M | 13.5 | 5.31 | ||||
AMRS | 3.7M | - | -0.01 | 0.01 |
Ingevity Corp News
Income Statement (Quarterly) | ||||||||||||||||||||||
Description | (%) Q/Q | 2023Q4 | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 | 2018Q4 |
Revenue | -16.7% | 372 | 446 | 482 | 393 | 384 | 482 | 420 | 383 | 336 | 377 | 358 | 320 | 326 | 332 | 271 | 288 | 303 | 360 | 353 | 277 | 279 |
Gross Profit | -53.9% | 60.00 | 129 | 153 | 130 | 105 | 176 | 151 | 138 | 105 | 142 | 140 | 126 | 127 | 140 | 84.00 | 115 | 111 | 140 | 134 | 97.00 | 98.00 |
S&GA Expenses | 8.5% | 43.00 | 40.00 | 52.00 | 49.00 | 56.00 | 54.00 | 49.00 | 40.00 | 48.00 | 44.00 | 48.00 | 40.00 | 42.00 | 35.00 | 35.00 | 39.00 | 41.00 | 41.00 | 43.00 | 39.00 | 36.00 |
R&D Expenses | -7.7% | 7.00 | 8.00 | 8.00 | 9.00 | 7.00 | 8.00 | 8.00 | 7.00 | 7.00 | 7.00 | 6.00 | 7.00 | 6.00 | 5.00 | 5.00 | 6.00 | 5.00 | 5.00 | 5.00 | 5.00 | 5.00 |
EBITDA Margin | -44.7% | 0.12* | 0.22* | 0.24* | 0.26* | 0.26* | 0.27* | 0.23* | 0.23* | 0.23* | 0.24* | 0.33* | 0.30* | - | - | - | - | - | - | - | - | - |
Interest Expenses | 97.8% | 35.00 | 18.00 | 25.00 | 15.00 | 26.00 | 7.00 | 18.00 | 11.00 | 16.00 | 11.00 | 13.00 | 12.00 | 1.00 | 14.00 | 7.00 | 17.00 | 15.00 | 19.00 | 7.00 | 14.00 | 11.00 |
Income Taxes | -639.1% | -37.20 | 7.00 | 12.00 | 13.00 | 4.00 | 20.00 | 17.00 | 17.00 | 7.00 | -4.80 | 29.00 | 13.00 | 20.00 | 18.00 | 5.00 | 10.00 | 11.00 | 18.00 | 16.00 | - | 2.00 |
Earnings Before Taxes | -579.8% | -154 | 32.00 | 48.00 | 64.00 | 20.00 | 96.00 | 77.00 | 78.00 | 36.00 | -9.00 | 74.00 | 62.00 | 66.00 | 88.00 | 25.00 | 55.00 | 55.00 | 77.00 | 73.00 | 23.00 | 44.00 |
EBT Margin | -106.2% | -0.01* | 0.10* | 0.13* | 0.15* | 0.16* | 0.18* | 0.12* | 0.12* | 0.12* | 0.14* | 0.22* | 0.19* | - | - | - | - | - | - | - | - | - |
Net Income | -563.5% | -116 | 25.00 | 36.00 | 51.00 | 16.00 | 75.00 | 60.00 | 61.00 | 29.00 | -4.20 | 44.00 | 49.00 | 46.00 | 70.00 | 20.00 | 45.00 | 44.00 | 60.00 | 57.00 | 23.00 | 42.00 |
Net Income Margin | -104.3% | 0.00* | 0.07* | 0.10* | 0.12* | 0.13* | 0.14* | 0.10* | 0.09* | 0.08* | 0.10* | 0.16* | 0.15* | - | - | - | - | - | - | - | - | - |
Free Cashflow | -58.3% | 45.00 | 107 | 48.00 | 5.00 | 98.00 | 100 | 91.00 | 24.00 | 76.00 | 100 | 66.00 | 51.00 | - | - | - | - | - | - | - | - | - |
Balance Sheet | ||||||||||||||||||||||
Description | (%) Q/Q | 2023Q4 | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 | 2018Q4 |
Assets | -5.2% | 2,623 | 2,767 | 2,828 | 2,772 | 2,737 | 2,335 | 2,366 | 2,456 | 2,469 | 2,426 | 2,389 | 2,343 | 2,335 | 2,258 | 2,196 | 2,353 | 2,142 | 2,119 | 2,130 | 2,107 | 1,315 |
Current Assets | -10.3% | 659 | 735 | 764 | 716 | 683 | 645 | 678 | 733 | 725 | 720 | 670 | 642 | 629 | 601 | 580 | 725 | 463 | 499 | 492 | 455 | 423 |
Cash Equivalents | 13.5% | 96.00 | 85.00 | 68.00 | 78.00 | 77.00 | 72.00 | 131 | 223 | 275 | 269 | 233 | 238 | 261 | 198 | 178 | 303 | 65.00 | 76.00 | 53.00 | 40.00 | 78.00 |
Inventory | -20.1% | 309 | 387 | 387 | 361 | 335 | 282 | 277 | 260 | 241 | 228 | 215 | 204 | 189 | 204 | 224 | 236 | 213 | 210 | 221 | 229 | 191 |
Net PPE | - | - | - | - | - | - | - | - | - | - | 701 | 700 | 698 | 704 | 685 | 658 | 660 | 665 | 642 | 638 | 629 | 524 |
Goodwill | 1.4% | 528 | 520 | 527 | 522 | 519 | 110 | 411 | 433 | 442 | 441 | 449 | 448 | 445 | 428 | 416 | 417 | 436 | 416 | 426 | 432 | 131 |
Liabilities | -2.7% | 1,992 | 2,048 | 2,114 | 2,047 | 2,038 | 1,702 | 1,712 | 1,770 | 1,795 | 1,782 | 1,701 | 1,681 | 1,692 | 1,641 | 1,673 | 1,851 | 1,611 | 1,676 | 1,729 | 1,749 | 977 |
Current Liabilities | 18.9% | 363 | 305 | 311 | 279 | 304 | 290 | 267 | 552 | 269 | 248 | 233 | 225 | 223 | 179 | 188 | 208 | 216 | 209 | 216 | 198 | 183 |
Long Term Debt | -5.9% | 1,383 | 1,470 | 1,526 | 1,503 | 1,473 | 1,153 | 1,176 | 946 | 1,250 | 1,254 | 1,259 | 1,263 | 1,267 | 1,277 | 1,309 | 1,468 | 1,228 | 1,294 | 1,363 | 1,403 | 741 |
LT Debt, Current | 2713.3% | 84.00 | 3.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 320 | 20.00 | 20.00 | 20.00 | 20.00 | 26.00 | 22.00 | 22.00 | 22.00 | 23.00 | 23.00 | 22.00 | 18.00 | 11.00 |
Shareholder's Equity | -12.1% | 631 | 719 | 714 | 726 | 698 | 634 | 654 | 686 | 674 | 645 | 689 | 661 | 642 | 617 | 523 | 502 | 531 | 443 | 401 | 359 | 339 |
Retained Earnings | -10.4% | 1,002 | 1,119 | 1,094 | 1,058 | 1,008 | 992 | 917 | 857 | 796 | 767 | 771 | 727 | 678 | 632 | 562 | 542 | 497 | 453 | 393 | 336 | 314 |
Additional Paid-In Capital | 1.4% | 165 | 163 | 164 | 159 | 153 | 148 | 143 | 140 | 136 | 133 | 130 | 125 | 121 | 117 | 116 | 114 | 113 | 111 | 108 | 104 | 98.00 |
Shares Outstanding | 0.0% | 36.00 | 36.00 | 36.00 | 37.00 | 37.00 | 37.00 | 38.00 | 39.00 | 39.00 | 39.00 | 40.00 | 40.00 | - | - | - | - | - | - | - | - | - |
Minority Interest | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Float | - | - | - | 2,102 | - | - | - | 2,401 | - | - | - | 3,237 | - | - | - | 2,162 | - | - | - | 4,384 | - | - |
Cashflow (Quarterly) | ||||||||||||||||||||||
Description | (%) Q/Q | 2023Q4 | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 | 2018Q4 |
Cashflow From Operations | -58.3% | 44,600 | 106,900 | 48,400 | 5,200 | 98,500 | 100,100 | 90,500 | 24,300 | 76,300 | 100,100 | 65,800 | 51,100 | 153,300 | 90,000 | 48,900 | 60,200 | 85,500 | 118,700 | 79,500 | -8,000 | 85,600 |
Share Based Compensation | 483.3% | 2,300 | -600 | 4,900 | 4,000 | 5,000 | 4,400 | 3,700 | 3,000 | 2,500 | 3,100 | 4,200 | 2,500 | 4,100 | 1,100 | 2,400 | 800 | 1,300 | 3,600 | 3,300 | 4,100 | 2,400 |
Cashflow From Investing | 39.7% | -21,000 | -34,800 | -23,400 | 1,900 | -407,200 | -86,100 | -28,400 | -30,200 | -55,200 | -26,200 | -39,900 | -17,300 | -32,200 | -41,000 | -17,200 | -20,200 | -35,900 | -23,100 | -30,000 | -569,300 | -38,100 |
Cashflow From Financing | 87.8% | -6,500 | -53,300 | -34,500 | -5,600 | 313,000 | -71,600 | -147,000 | -46,300 | -12,800 | -36,700 | -31,500 | -52,100 | -65,000 | -31,100 | -157,300 | 203,200 | -64,400 | -71,200 | -34,600 | 539,400 | -26,200 |
Buy Backs | - | - | - | 58,700 | 33,400 | 6,000 | 49,300 | 49,500 | 40,400 | 9,100 | 32,200 | 28,700 | 39,400 | 55,600 | - | - | 32,400 | - | 3,100 | - | 3,300 | 29,300 |
Consolidated Statements of Operations - USD ($) $ in Millions | 12 Months Ended | ||
---|---|---|---|
Dec. 31, 2023 | Dec. 31, 2022 | Dec. 31, 2021 | |
Income Statement [Abstract] | |||
Net sales | $ 1,692.1 | $ 1,668.3 | $ 1,391.5 |
Cost of sales | 1,220.2 | 1,098.2 | 878.7 |
Gross profit | 471.9 | 570.1 | 512.8 |
Selling, general, and administrative expenses | 183.7 | 198.8 | 179.3 |
Research and technical expenses | 31.8 | 30.3 | 26.3 |
Restructuring and other (income) charges, net | 170.2 | 13.8 | 16.2 |
Acquisition-related costs | 3.6 | 5.0 | 0.6 |
Other (income) expense, net | 5.7 | (1.7) | 79.9 |
Interest expense | 93.3 | 61.8 | 51.7 |
Interest income | (6.3) | (7.5) | (4.0) |
Income (loss) before income taxes | (10.1) | 269.6 | 162.8 |
Provision (benefit) for income taxes | (4.7) | 58.0 | 44.7 |
Net income (loss) | $ (5.4) | $ 211.6 | $ 118.1 |
Per share data | |||
Basic earnings (loss) per share (usd per share) | $ (0.15) | $ 5.54 | $ 2.97 |
Diluted earnings (loss) per share (usd per share) | $ (0.15) | $ 5.50 | $ 2.95 |
Consolidated Balance Sheets - USD ($) $ in Millions | Dec. 31, 2023 | Dec. 31, 2022 |
---|---|---|
Assets | ||
Cash and cash equivalents | $ 95.9 | $ 76.7 |
Accounts receivable, net of allowance of $1.1 million - 2023 and $0.5 million - 2022 | 182.0 | 224.8 |
Inventories, net | 308.8 | 335.0 |
Prepaid and other current assets | 71.9 | 46.8 |
Current assets | 658.6 | 683.3 |
Property, plant, and equipment, net | 762.2 | 798.6 |
Operating lease assets, net | 67.1 | 56.6 |
Goodwill | 527.5 | 518.5 |
Other intangibles, net | 336.1 | 404.8 |
Deferred income taxes | 11.6 | 5.7 |
Restricted investment, net of allowance of $0.2 million - 2023 and $0.6 million - 2022 | 79.1 | 78.0 |
Strategic investments | 99.2 | 109.8 |
Other assets | 81.9 | 81.2 |
Total Assets | 2,623.3 | 2,736.5 |
Liabilities | ||
Accounts payable | 158.4 | 174.8 |
Accrued expenses | 72.3 | 54.4 |
Accrued payroll and employee benefits | 19.9 | 53.3 |
Current operating lease liabilities | 18.7 | 16.5 |
Notes payable and current maturities of long-term debt | 84.4 | 0.9 |
Income taxes payable | 9.2 | 3.6 |
Current liabilities | 362.9 | 303.5 |
Long-term debt including finance lease obligations | 1,382.8 | 1,472.5 |
Noncurrent operating lease liabilities | 48.6 | 40.8 |
Deferred income taxes | 70.9 | 106.5 |
Other liabilities | 126.7 | 114.9 |
Total Liabilities | 1,991.9 | 2,038.2 |
Equity | ||
Preferred stock (par value $0.01 per share; 50,000,000 shares authorized; zero issued and outstanding at 2023 and 2022) | 0.0 | 0.0 |
Common stock (par value $0.01 per share; 300,000,000 shares authorized; 43,446,513 and 43,228,172 issued and 36,233,092 and 37,298,989 outstanding at 2023 and 2022, respectively) | 0.4 | 0.4 |
Additional paid-in capital | 164.9 | 153.0 |
Retained earnings | 1,002.3 | 1,007.7 |
Accumulated other comprehensive income (loss) | (26.7) | (46.8) |
Treasury stock, common stock, at cost (7,213,421 and 5,929,183 shares at 2023 and 2022, respectively) | (509.5) | (416.0) |
Total Ingevity stockholders' equity | 631.4 | 698.3 |
Total Liabilities and Equity | $ 2,623.3 | $ 2,736.5 |
 | Mr. John C. Fortson |
---|---|
 | www.ingevity.com |
 | 2050 |